Stock Markets April 6, 2026

Owlet names co-founder Kurt Workman as CEO; shares climb 8% in after-hours trade

Company restates near-term revenue outlook, emphasizes path to profitability and long-term pediatric health strategy

By Hana Yamamoto OWLT
Owlet names co-founder Kurt Workman as CEO; shares climb 8% in after-hours trade
OWLT

Owlet Inc. said co-founder Kurt Workman will return to the chief executive role immediately after Jonathan Harris resigned. The stock rose 8% in after-hours trading. The company reaffirmed its first quarter 2026 revenue guidance at the high end of the range, plans an early May report of Q1 results and underscored long-term strategic priorities while its CFO elected to take her 2025 bonus fully in stock.

Key Points

  • Immediate CEO transition as Kurt Workman replaces Jonathan Harris following an effective immediate resignation.
  • Owlet expects to reach the high end of its first quarter 2026 revenue guidance and will report results and outlook in early May 2026.
  • Company reaffirms long-term pillars and a path to profitability; CFO opted to receive 100% of her 2025 bonus in stock.

Leadership change and market reaction

Owlet Inc. (NYSE:OWLT) announced that co-founder Kurt Workman will step into the position of President and Chief Executive Officer following the immediate resignation of Jonathan Harris. Shares of the smart infant monitoring company rose 8% in after-hours trading on the news.

Workman, who had previously served as CEO and who is currently Executive Chair of the Board, will lead execution of the company’s stated strategic priorities. He will continue to serve on the board as a director but will cease serving as Executive Chair.

Board comment and company positioning

The board expressed appreciation for Harris’ leadership and service. Lior Susan, Owlet’s Chairman of the Board, said that Workman’s strategic vision and proven ability to execute make him well suited to guide the company as it moves into its next phase.

Guidance, reporting and financial discipline

Owlet indicated it expects to reach the high end of its first quarter 2026 revenue guidance range. The company plans to release first quarter 2026 financial results and an updated business outlook in early May 2026.

Management reiterated a commitment to achieving profitability through a combination of revenue growth, disciplined expense management, and operational excellence. The company also reaffirmed its long-term strategic pillars: increasing adoption, expanding lifetime value, and leveraging its data set to build a pediatric health platform.

Executive compensation signal

As an additional signal of alignment with the long-term plan, Chief Financial Officer Amanda Twede Crawford has elected to receive 100% of her 2025 annual bonus in Owlet common stock rather than cash.

Incoming CEO remarks

Workman described his return to the CEO role as a recommitment to the mission he began 12 years ago. He said his objective is to position Owlet as the standard for at-home pediatric health, citing the company’s role as a category leader in pediatric health monitoring and its extensive data set as the basis for expanding market penetration and accelerating adoption.


Key points

  • Immediate CEO transition as co-founder Kurt Workman replaces Jonathan Harris following Harris’ resignation effective immediately.
  • Owlet expects to reach the high end of its Q1 2026 revenue guidance and will report results and outlook in early May 2026.
  • Company reiterates focus on profitability via revenue growth, expense discipline and operational excellence; CFO to take 2025 bonus fully in stock.

Sectors affected

  • Healthcare technology and pediatric monitoring - direct impact on category competitors and device makers.
  • Consumer electronics and wearable health devices - implications for distribution, pricing and adoption dynamics.

Risks and uncertainties

  • Leadership transition risk - the immediate change in chief executive could create short-term execution uncertainty for the company and its operational plans.
  • Execution on guidance and profitability - while the company expects to reach the high end of Q1 2026 revenue guidance, delivering sustained profitability depends on continued revenue growth and expense discipline.
  • Adoption and market penetration - achieving long-term strategic goals requires increasing customer adoption and lifetime value, outcomes that are uncertain and tied to market response.

What to watch next

Investors will be attentive to the Q1 2026 financial results and business outlook, due in early May 2026, for details on revenue performance, margins, and management's plan to reach profitability.

Risks

  • Leadership transition may introduce short-term execution uncertainty - impacts healthcare technology and consumer device markets.
  • Delivering sustained profitability depends on continued revenue growth and strict expense discipline - impacts investors and financial markets.
  • Long-term strategic goals depend on increasing adoption and lifetime value, which remain uncertain - affects pediatric health monitoring sector.

More from Stock Markets

OpenAI Asks California and Delaware Attorneys General to Probe Alleged Anti-Competitive Conduct by Elon Musk and Associates Apr 6, 2026 Broadcom Secures Multi-Year TPU and Networking Supply Deals with Google; Shares Rise After-Hours Apr 6, 2026 Mexican Equities Slip as Major Sectors Drag Index Down 1.03% Apr 6, 2026 Colombian equities finish higher as COLCAP reaches one-month peak Apr 6, 2026 MOEX Russia Index Climbs 0.91% as Mining, Oil & Gas Lead Gains Apr 6, 2026